IQVIA cash flow statement
In fiscal 2025, IQVIA's operations generated $2.65bn of cash; it spent $603m on capital projects, leaving free cash flow of $2.05bn. It returned $1.24bn through buybacks.
Cash flow statement
| Fiscal year | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMSept 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 161 | 336 | 393 | 433 | 476 | 860 | 970 | 1,254 | 1,417 | 1,959 | 2,942 | 2,260 | 2,149 | 2,716 | 2,654 | 2,736 |
| Depreciation and amortisation | 92 | 98 | 108 | 121 | 128 | 289 | 1,011 | 1,141 | 1,202 | 1,287 | 1,264 | 1,130 | 1,125 | 1,114 | 1,144 | 1,218 |
| Stock-based pay | 14 | 26 | 23 | 30 | 38 | 106 | 106 | 113 | 146 | 95 | 170 | 194 | 217 | 206 | 247 | 300 |
| Capital spending | 76 | 71 | 88 | 83 | 78 | 164 | 369 | 459 | 582 | 616 | 640 | 674 | 649 | 602 | 603 | 657 |
| Free cash flow | 85 | 264 | 305 | 350 | 398 | 696 | 601 | 795 | 835 | 1,343 | 2,302 | 1,586 | 1,500 | 2,114 | 2,051 | 2,079 |
| Free cash flow after stock pay | 71 | 238 | 282 | 320 | 360 | 590 | 495 | 682 | 689 | 1,248 | 2,132 | 1,392 | 1,283 | 1,908 | 1,804 | 1,779 |
| Dividends paid | 288 | 568 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Share buybacks | 14 | 13 | 6 | 415 | 515 | 1,097 | 2,620 | 1,405 | 949 | 447 | 406 | 1,168 | 992 | 1,350 | 1,244 | 1,162 |
| Shares issued | — | 3 | 525 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Quarter | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 | 2026 Q3Sept 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 885 | 568 | 443 | 908 | 735 | 618 | 558 | 825 |
| Depreciation and amortisation | 303 | 265 | 276 | 286 | 317 | 288 | 292 | 321 |
| Stock-based pay | 48 | 72 | 52 | 51 | 60 | 65 | 93 | 82 |
| Capital spending | 164 | 142 | 151 | 136 | 174 | 127 | 198 | 158 |
| Free cash flow | 721 | 426 | 292 | 772 | 561 | 491 | 360 | 667 |
| Free cash flow after stock pay | 673 | 354 | 240 | 721 | 501 | 426 | 267 | 585 |
Compare with peers
- Danaher Corporation cash flow
- Icon PLC cash flow
- Agilent Technologies cash flow
- Avantor, Inc. cash flow
- Thermo Fisher Scientific cash flow
Head to head: DHR vs IQVICLR vs IQVA vs IQVIQV vs TMO
More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies